Delivery Order SPE2DB20D2014-SPE2DB25FB82G
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a ceiling value of $1,970.64 and is a firm fixed-price, non-set-aside contract with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $2,029.10 and a performance period through April 16, 2025. The contract is not set-aside and was awarded on April 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,414.00, is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $6,684.15 and a performance period ending on April 10, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,525.00 contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,037.92 contract is for the supply of 4,568,060,918 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes treatment medication, at a firm fixed price of $2,227.55. The contract has an ultimate completion date of April 23, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,470.32 firm fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of February 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes treatment medication, with a ceiling value of $14,035.20. The contract is a firm fixed price, non-set-aside award with a performance period ending on May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,479.00, is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract is a firm fixed-price delivery order with a period of performance through May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...